Latest Publications
Three Essential Concerns for a Safe and Effective Aseptic Filling Process
Aseptic filling equipment can be complicated to operate but is the safest option for manufacturing parenterals that cannot undergo terminal sterilization. The goal of any aseptic filling process is to completely eliminate microorganism and [...]
Patenting Physical Forms in the Pharmaceutical Industry
Using intellectual property laws to secure physical form patents for new drugs first made headlines some thirty years ago. These attention-grabbing lawsuits centered around paroxetine (Paxil), ranitidine (Zantac), and other blockbuster drugs. Generics were attempting [...]
Optimizing Upstream and Downstream Processes in Biologics Manufacturing Yields Significant Savings
Pipeline enhancements increase biologic yields while lowering costs. Bioprocessing involves utilizing cultured cell lines to procure biological products. Pharmaceutical bioprocessing is often used to produce proteins such as monoclonal antibodies (mAbs), gene therapy vectors, and [...]
Injectable Biologic Formulation Has Developed Substantially in Recent Years, but Several Major Challenges Remain
Injectable biologics have some of the heaviest regulations of any pharmaceutical therapy. The US Food and Drug Administration (FDA) insists that anti-contamination protocols be followed throughout the manufacturing and packaging processes, with all personnel, equipment, [...]
In The Press
Praesent lectus leo, convallis id neque nec, ultrices euismod nibh. Sed ac rhoncus quam. Fusce tristique tellus diam, vel porta eros iaculis vitae.
Three Essential Concerns for a Safe and Effective Aseptic Filling Process
Aseptic filling equipment can be complicated to [...]
Patenting Physical Forms in the Pharmaceutical Industry
Using intellectual property laws to secure physical form [...]
Optimizing Upstream and Downstream Processes in Biologics Manufacturing Yields Significant Savings
Pipeline enhancements increase biologic yields while lowering costs. [...]
Injectable Biologic Formulation Has Developed Substantially in Recent Years, but Several Major Challenges Remain
Injectable biologics have some of the heaviest regulations [...]
Despite Individual Fluctuations, the Collective Success Rate of Monoclonal Antibody Therapies Continues to Rise
In terms of clinical studies, the human monoclonal [...]
Quality Control in Commercial Tablet Manufacturing
Two out of every three prescriptions in the [...]
Emerging Alternatives to Animal Models for Toxicology Testing
The subject of animal testing by the pharmaceutical [...]
On-Going Research
Praesent lectus leo, convallis id neque nec, ultrices euismod nibh. Sed ac rhoncus quam. Fusce tristique tellus diam, vel porta eros iaculis vitae.
Three Essential Concerns for a Safe and Effective Aseptic Filling Process
Aseptic filling equipment can be complicated to operate but is the safest option for manufacturing parenterals that cannot undergo terminal sterilization. The goal of any aseptic filling process is to completely eliminate microorganism and [...]
Patenting Physical Forms in the Pharmaceutical Industry
Using intellectual property laws to secure physical form patents for new drugs first made headlines some thirty years ago. These attention-grabbing lawsuits centered around paroxetine (Paxil), ranitidine (Zantac), and other blockbuster drugs. Generics were attempting [...]
Optimizing Upstream and Downstream Processes in Biologics Manufacturing Yields Significant Savings
Pipeline enhancements increase biologic yields while lowering costs. Bioprocessing involves utilizing cultured cell lines to procure biological products. Pharmaceutical bioprocessing is often used to produce proteins such as monoclonal antibodies (mAbs), gene therapy vectors, and [...]
Injectable Biologic Formulation Has Developed Substantially in Recent Years, but Several Major Challenges Remain
Injectable biologics have some of the heaviest regulations of any pharmaceutical therapy. The US Food and Drug Administration (FDA) insists that anti-contamination protocols be followed throughout the manufacturing and packaging processes, with all personnel, equipment, [...]
Despite Individual Fluctuations, the Collective Success Rate of Monoclonal Antibody Therapies Continues to Rise
In terms of clinical studies, the human monoclonal antibody (mAb) sector is expanding faster than any other class of mAb therapeutics. The “chimeric” quality of some mAbs allows for a range of exciting developments. Many [...]
Quality Control in Commercial Tablet Manufacturing
Two out of every three prescriptions in the United States are administered via solid dose form, and nearly 50% of these solid dose prescriptions are administered in the form of compressed tablets. This makes compressed [...]